Advertorial

Manufacturing & Processing - Serving India and Beyond

Venus Remedies,

Having gained a h4 foothold in India\'s domestic sector, one Haryana-based company specialising in super speciality injectable drugs is working towards expanding its place in the world pharmaceuticals market.

Established in 1991, Venus Remedies Limited is a wholly Indian owned company, recognised as one of the most dynamic growth-and result-oriented companies in India. Its range of super speciality injectables covers the areas of:

Anti-cancer
Carbapenem
Chephalosporin
Over the counter (OTC) pharma

Technical Base

Venus' strength lies in its in-house R&D department, which boasts a panel of technical experts who are dedicated to the creation of new products in the therapeutic areas of FDCs and NSAIDs. The department has filed five patent applications for in-house research projects:

Treatment and control of severe infections including cystis fibrosis
Composition for combating beta-lactum medicated antibiotic resistance using betalactamase inhibitors useful for injection
Antibiotic combinations for providing total solution to the treatment of infections
Non-aqueous liquid parenteral NSAID formulation
Parenteral combination therapy for infective conditions with drug resistance bacterium

New Projects

Venus has created history with the launch of a single new formulation for generating a blockbuster in a short span of time. Other exciting projects the R&D department are working on include:

Drug delivery systems. Developing technology for manufacturing drugs in injectable and oral forms.
Fixed dose combinations. The development of more effective formulations by combining two or more APIs for an improved formulation with the effectiveness of both APIs and shorter treatment spans due to improved efficacy.

Venus' four dedicated state-of-the-art manufacturing facilities operate to the standards of US FDA and UK MHRA, and it is in the process of seeking international approval. The facilities comprise:

Anti-cancer injectable
Anti-cancer lypholised injectable
Carbapenem
Chephalosporin

Building the Future

Venus was first set up as a manufacturer of IV fluids. In 1994, it became a public limited company and expanded its operations to produce liquid vials, ampoules and dry powder injectables, followed by antibiotics, antihistamines and oncology drugs.

Venus has a h3 share in India's domestic pharmaceutical market, having supplied IV fluids to the northern India states, as well as to governmental institutions of Kerala, Karnataka and Haryana. The company's markets are not limited to India: it exports drugs to Nepal, Ukraine and Yemen. Venus clients include: Panacea Biotech, Sanat Products, Elder Pharmaceuticals, Jagsonpal Pharmaceuticals, Samarth Pharma, Ipca Laboratories and Lyka BDR Pharma.

Venus is keen to expand its global business and seeks partners for custom manufacturing, contract research, strategic marketing tie-ups, collaborations and joint ventures to further strengthen and consolidate its marketing alliances and manufacturing base. The company's strengths lie in the manufacture of sophisticated, super speciality products with timely deliveries, and it is constantly striving to deliver quality and satisfaction in the shortest time.